149 related articles for article (PubMed ID: 11397625)
1. Another look at differences in the susceptibility of Escherichia coli and Klebsiella pneumoniae to cephalothin and cefazolin.
Yeh LL; Chi CL
Int J Antimicrob Agents; 2001 Jun; 17(6):521-4. PubMed ID: 11397625
[TBL] [Abstract][Full Text] [Related]
2. Relationships between in vitro susceptibility and efficacy in experimental mouse infection-protection assay of cefazolin and cephalothin using Escherichia coli strains.
Uri JV; Actor P; Phillips L; Guarini JR; Weisbach JA
Chemotherapy; 1976; 22(5):313-8. PubMed ID: 780071
[TBL] [Abstract][Full Text] [Related]
3. [Susceptibility to first-generation Cephalosporins in Enterobacteriaceae isolated from urine culture according to CLSI and EUCAST breakpoints].
Corvalán V; Hervé B; Sanhueza C; Martínez N; Almonacid M; Fuente S
Rev Chilena Infectol; 2018; 35(3):329-331. PubMed ID: 30534916
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of antibacterial activities of cephalosporin antibiotics: cefazolin, cephaloridine, cephalothin, and cephalexin.
Hsieh WC; Ho SW
Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1975 Mar; 8(1):1-11. PubMed ID: 1097210
[TBL] [Abstract][Full Text] [Related]
5. E. coli, K. pneumoniae and K. oxytoca community-acquired infections susceptibility to cephalosporins and other antimicrobials in Lebanon.
Moghnieh RA; Musharrafieh UM; Husni RN; Abboud E; Haidar M; Abboud E; Abou Shakra D
J Med Liban; 2014; 62(2):107-12. PubMed ID: 25011373
[TBL] [Abstract][Full Text] [Related]
6. Differential susceptibility of indole-positive and -negative strains of Klebsiella pneumoniae to cefazolin, choramphenicol and tetracycline.
Nishida M; Asano H; Kamimura T; Yokota Y
Chemotherapy; 1978; 24(3):154-60. PubMed ID: 350514
[TBL] [Abstract][Full Text] [Related]
7. Update of incidence and antimicrobial susceptibility trends of Escherichia coli and Klebsiella pneumoniae isolates from Chinese intra-abdominal infection patients.
Zhang H; Yang Q; Liao K; Ni Y; Yu Y; Hu B; Sun Z; Huang W; Wang Y; Wu A; Feng X; Luo Y; Chu Y; Chen S; Cao B; Su J; Duan Q; Zhang S; Shao H; Kong H; Gui B; Hu Z; Badal R; Xu Y
BMC Infect Dis; 2017 Dec; 17(1):776. PubMed ID: 29254478
[TBL] [Abstract][Full Text] [Related]
8. Trends in Expanded-Spectrum Cephalosporin-Resistant Escherichia coli and Klebsiella pneumoniae among Dutch Clinical Isolates, from 2008 to 2012.
van der Steen M; Leenstra T; Kluytmans JA; van der Bij AK;
PLoS One; 2015; 10(9):e0138088. PubMed ID: 26381746
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Escherichia coli susceptibility to cephalothin, cefazolin, ceforanide, and cefamandole.
Greenberg RN; Bollinger M
Clin Ther; 1985; 7(2):151-3. PubMed ID: 3886140
[TBL] [Abstract][Full Text] [Related]
10. In vitro susceptibility of cephalothin-resistant Enterobacteriaceae to cefoxitin and BL-S786.
Meyer RD
J Antibiot (Tokyo); 1977 Apr; 30(4):326-9. PubMed ID: 324961
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic confirmation of extended-spectrum B-lactamases (ESBL) in clinical isolates of Escherichia coli and Klebsiella pneumoniae at the San Juan Veterans Affairs Medical Center.
Del Carmen Rodríguez M; Vera DE; Ramírez-Ronda CH; Saavedra S
P R Health Sci J; 2004 Sep; 23(3):207-15. PubMed ID: 15631176
[TBL] [Abstract][Full Text] [Related]
12. Cephalothin and cefazolin in vitro antibacterial activity and pharmacokinetics in dogs.
Petersen SW; Rosin E
Vet Surg; 1995; 24(4):347-51. PubMed ID: 7571387
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of cefazolin as a surrogate marker for cefpodoxime susceptibility for urinary tract isolates.
Bookstaver DA; Bland CM; Arroyo MA
J Med Microbiol; 2015 Oct; 64(10):1170-1173. PubMed ID: 26219948
[TBL] [Abstract][Full Text] [Related]
14. Extended spectrum b lactamases (ESBL) in clinical isolates of Klebsiella pneumoniae and Escherichia coli.
Duttaroy B; Mehta S
Indian J Pathol Microbiol; 2005 Jan; 48(1):45-8. PubMed ID: 16758790
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial susceptibilities of urinary extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae to fosfomycin and nitrofurantoin in a teaching hospital in Taiwan.
Liu HY; Lin HC; Lin YC; Yu SH; Wu WH; Lee YJ
J Microbiol Immunol Infect; 2011 Oct; 44(5):364-8. PubMed ID: 21524974
[TBL] [Abstract][Full Text] [Related]
16. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases.
Tsui K; Wong SS; Lin LC; Tsai CR; Chen LC; Huang CH
J Microbiol Immunol Infect; 2012 Jun; 45(3):193-9. PubMed ID: 22580086
[TBL] [Abstract][Full Text] [Related]
17. Cefazolin as a predictor of urinary cephalosporin activity in indicated Enterobacterales.
Bryson AL; Bhalodi A; Liesman RM; Mathers AJ
J Clin Microbiol; 2024 Apr; 62(4):e0078821. PubMed ID: 38457194
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterization of integrons in clinical isolates of betalactamase-producing Escherichia coli and Klebsiella pneumoniae in Iran.
Zeighami H; Haghi F; Hajiahmadi F
J Chemother; 2015 Jun; 27(3):145-51. PubMed ID: 24571248
[TBL] [Abstract][Full Text] [Related]
19. Nosocomial bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae resistant to third-generation cephalosporins, Finland, 1999-2013: Trends, patient characteristics and mortality.
Martelius T; Jalava J; Kärki T; Möttönen T; Ollgren J; Lyytikäinen O;
Infect Dis (Lond); 2016; 48(3):229-34. PubMed ID: 26577519
[TBL] [Abstract][Full Text] [Related]
20. Is There an Association Between Use of Amoxicillin-Clavulanate and Resistance to Third-Generation Cephalosporins in Klebsiella pneumoniae and Escherichia coli at the Hospital Level?
Marquet A; Vibet MA; Caillon J; Javaudin F; Chapelet G; Montassier E; Batard E
Microb Drug Resist; 2018 Sep; 24(7):987-994. PubMed ID: 29489447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
